logo
* 搜尋
* 核能資訊中心
* 中心簡介
* 相關資訊
* 瀏覽人數
今天: 29
昨天: 251
本月: 3896
總計: 551815
國際核能現況 : Bruce Power and ITM to supply cancer therapy isotope
發表人 nicenter 於 2018/7/2 10:40:05 (86 人讀取)

Bruce Power and ITM to supply cancer therapy isotope


Bruce Power and ITG, a subsidiary of radiopharmaceutical technology company ITM Isotopen Technologien München (ITM), have launched a joint effort to explore the production of the medical radioisotope lutetium-177 (Lu-177) at Bruce Power's Candu reactors.



Bruce-ITM_Lu-177_MOU_June18_(Bruce)-460

ITM's Mark Harfensteller, seated at left, signs the MoU with Bruce's James Scongack, front centre. Also shown are Bruce Power's Pat Dalzell at front right, with ITM's Ingo Russnak and Bruce Power's Kurt Wigle standing. (Image: Bruce Power)


Lu-177 is used in targeted radionuclide therapy to treat cancers like neuroendocrine tumours and prostate cancer. The medical-grade radioisotope is used to destroy cancer cells while leaving healthy cells unaffected.


The companies yesterday announced the signature of a Memorandum of Understanding to explore the production of Lu-177 at Bruce, which they say has the ability to meet global supply needs until 2064. The partnership aims to meet the medical community's growing demand for the radioisotope. Development, processing, and global distribution of Lu-177 will be managed by ITG.


Bruce's Candu units already produce cobalt-60, which is used for the sterilisation of medical equipment and in a specialised form of cancer treatment called the Gamma Knife. The company is part of the recently established Canadian Nuclear Isotope Council, which aims to develop collective solutions to maintain Canada's leadership position on the global isotope stage following the shut-down earlier this year of the National Research Universal reactor after over 60 years of operation.


Bruce Power in 2017 signed an agreement with Areva NP - now Orano - for Areva to design and supply equipment to be installed in the existing Bruce Candu units to add online production at commercial scale of a wide range of isotopes including short half-life isotopes such as Mo-99, Lu-177 and iridium-192 using a system that inserts and removes targets with little impact on the normal operation of the power reactors.


"Bruce Power is a world leader in the production of critical radioisotopes used to treat cancer," said Mike Rencheck, Bruce Power's president and CEO. "By developing innovative ways to generate these radioisotopes, we help ensure that the medical community has access to a reliable source of medical radioisotopes for Targeted Radionuclide Therapy."


Steffen Schuster, CEO of ITM, said: "With Bruce Power's long-term outlook to operate its facility through 2064 and its existing expertise with cobalt production, we have the opportunity to provide a stable source of lutetium-177 to cancer patients worldwide."


Researched and written
by World Nuclear News



source: http://www.world-nuclear-news.org/RS-Bruce-Power-and-ITM-to-supply-cancer-therapy-isotope-2906187.html



其他新聞
2018/11/21 9:26:55 - South Africa to resume radioisotope production
2018/11/21 9:25:09 - Renewables experience could benefit US SMR deployment
2018/11/21 9:22:08 - 原能會持續審查及現場視察核二廠1號機第26次大修再起動申請案
2018/11/21 9:19:20 - 回應空污遊行訴求 台電火力電廠積極投入改善 致力減少空污排放
2018/11/19 9:34:29 - PRISM selected for US test reactor programme
2018/11/19 9:27:09 - UK HPR1000 moves to next design assessment stage
2018/11/19 9:25:07 - Orano prepares Fugen ATR fuel for reprocessing
2018/11/14 9:20:55 - 行政院107年11月8日通過核研所改行政院法人「原子能科技研究院」
2018/11/14 9:14:47 - 原能會於今(13)日接獲台電公司核二廠1號機第26次大修後再起動臨界申請
2018/11/9 9:44:29 - Toshiba decides to scrap Moorside project
2018/11/7 9:30:04 - Hurricane-hit Puerto Rico to consider nuclear power
2018/11/7 9:28:12 - Saudi Arabia lays research reactor foundation stone
2018/11/7 9:25:41 - First reactor on Russia's floating plant starts up
2018/11/7 9:21:42 - Cameco notes market improvements
2018/11/5 9:36:36 - UK, Canada sign Nuclear Cooperation Agreement
2018/11/5 9:34:12 - Idaho proposed for HALEU fuel fabrication
2018/11/5 9:32:35 - IAEA reviews long-term safety of Argentinean plant
2018/11/5 9:30:50 - Decommissioning milestone for space fuel plant
2018/11/5 9:26:17 - 除役首部曲 核一乾貯核定計畫遭新北市府認定失效 台電今再提訴願
2018/11/2 9:51:26 - Climate goal demands huge boost in Chinese nuclear

 線上期刊目錄

 友善連結

單位類

行政院原子能委員會
放射性物料管理局
核能研究所
國立清華大學工程與系統科學系
國立清華大學生醫工程與環境科學系
中華民國核能學會
財團法人核能科技協進會

新聞類


30013 新竹市光復路二段101號 創新育成中心三樓309室 電話:(03)571-1808 傳真:(03)572-5461 Email: nicenter@nicenter.org.tw